Mitotic activity in ovarian follicles was studied in relation to the size of the follicles during a 24-hour period (10.00, 16.00, 22.00 and 04.00 h) throughout the estrous cycle of the wild bandicoot rat (Bandicota bengalensis) to ascertain the cell proliferation rate and its 24-hour rhythm in the follicular tissue. In the bandicoot ovary, mitotic activity in the granulosa and thecal cells was highest in the follicles ranging from 201 to 400 µm in diameter. During the estrous cycle, mitotic activity of the granulosa cells was highest at estrus in follicles < 601 µm, and at diestrus in follicles > 600 µm; while the mitotic trough was at proestrus in all the follicles. Thecal mitosis was significantly lower than mitosis of the granulosa cells. In most of the follicles, mitotic activity in the thecal cells was highest at diestrus and lowest at metestrus. In both the granulosa and thecal cells, the timing of mitotic peaks and troughs varied according to the size of the follicles and the stages of the estrous cycle. In the granulosa cells mitotic peaks were maximal in the daytime (10.00 h, 16.00 h) and in some cases at night (04.00 h); and mitotic troughs were primarily during the night (22.00 h, 04.00 h) and in some cases in the day (10.00 h). In the thecal cells, however, mitotic activity in most of the follicles was distinctly higher in the daytime (16.00 h) than at night (22.00 h, i.e., evening). Thus, a prominent 24-hour mitotic rhythm was noticed in the ovarian follicles of the bandicoot rat.

Keywords:
Ovarian follicles, Wild rat, Mitotic activity, Circadian rhythm
This content is only available via PDF.
© 1985 S. Karger AG, Basel
1985
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.